Pyridines and derivatives
1
–
2
of
2
results
1
Medchemexpress LLC Vipivotide tetraxetan | 1702967-37-0 | MFCD31715458 | 99.5% | 1042.14 | C49H71N9O16 | 50 MG
Vipivotide tetraxetan is a DOTA-conjugated small-molecule ligand that selectively binds prostate-specific membrane antigen (PSMA) and is supplied as a research precursor for radiolabeling with diagnostic and therapeutic radionuclides. It is used in preclinical and clinical research for PSMA-targeted imaging and radioligand therapy.
- DOTA-conjugated PSMA-targeting ligand suitable for radiolabeling with lutetium-177 or gallium-68.
- High binding affinity for PSMA enabling targeted imaging and therapy applications.
- Supplied with high purity (≈99.5%), appropriate for research use.
- Available in multiple pack sizes, including 50 mg for synthesis and labeling workflows.
- Useful as a precursor for developing PSMA-targeted radiopharmaceuticals.
2
Medchemexpress LLC Zadavotide guraxetan | 2192281-54-0 | 99.9% | 1498.37 g/mol | C63H92IN11O23 | 100 MG
Zadavotide guraxetan is a prostate-specific membrane antigen (PSMA)-targeting small-molecule ligand used as a research precursor for PSMA-directed imaging and radioligand studies, including lutetium-177 conjugation. Intended for research use only.
- PSMA-targeting ligand suitable for radiolabeling and imaging applications.
- Reported high purity supports analytical and radiochemistry workflows.
- Available as a solid in multiple pack sizes, including 100 mg.
- CAS number 2192281-54-0 for unambiguous identification.
- Molecular weight 1498.37 g/mol and chemical formula C63H92IN11O23.